Hedy Kindler to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Hedy Kindler has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
0.944
-
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations. J Thorac Oncol. 2025 Nov; 20(11):1615-1625.
Score: 0.877
-
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904. J Thorac Oncol. 2008 Apr; 3(4):417-21.
Score: 0.066